Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Chemically Synthesized Medicines
100,0
%
| 14 | 100,0 % | 27 | 100,0 % | +86.52% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 14 | 100,0 % | 27 | 100,0 % | +86.52% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Kevin Lee
CEO | Chief Executive Officer | 55 | 01.09.15 |
Alethia Young
DFI | Director of Finance/CFO | 45 | 17.07.23 |
Alistair Milnes
COO | Chief Operating Officer | 50 | 01.01.21 |
Michael Skynner
CTO | Chief Tech/Sci/R&D Officer | 55 | 01.01.16 |
Nicholas Keen
CTO | Chief Tech/Sci/R&D Officer | 56 | 01.01.17 |
David Borah
IRC | Investor Relations Contact | - | 01.04.21 |
Jennifer Perry
PRN | Corporate Officer/Principal | - | - |
Travis Thompson
AUD | Comptroller/Controller/Auditor | - | 01.04.18 |
Zafar Qadir
LAW | General Counsel | - | 23.04.20 |
Santiago Arroyo
PRN | Corporate Officer/Principal | 64 | 31.03.23 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Pierre Legault
CHM | Chairman | 63 | 18.03.19 |
Director/Board Member | 61 | 17.03.21 | |
Richard Kender
BRD | Director/Board Member | 68 | 24.07.19 |
Janice Bourque
BRD | Director/Board Member | 67 | 18.07.19 |
Gregory Winter
FOU | Founder | 73 | 01.01.09 |
Kevin Lee
CEO | Chief Executive Officer | 55 | 01.09.15 |
Stephen Sands
BRD | Director/Board Member | 67 | 20.02. |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 37 880 303 | 4 333 333 ( 11,44 %) | 0 | 11,44 % |
Unternehmenskontakt
Bicycle Therapeutics Plc
Granta Park Great Abington Portway Building
CB21 6GS, Cambridge
+44 1223 261 503
http://bicycletherapeutics.comSektor
Umsatz je Region
% 1. Jan. | Kap. | |
---|---|---|
-2.31% | 103 Mrd. | |
+0.56% | 95.28 Mrd. | |
+1.69% | 22.15 Mrd. | |
-17.37% | 21.02 Mrd. | |
-9.30% | 18.15 Mrd. | |
-41.01% | 16.74 Mrd. | |
-14.85% | 16.05 Mrd. | |
+3.21% | 13.68 Mrd. | |
+33.54% | 12.17 Mrd. |